# Migraine: Developing Drugs for Acute Treatment - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/migraine-developing-drugs-for-acute-treatment/39ba4b4b-6c93-4849-a087-866c6bf4edff

> FDA guidance document: Migraine: Developing Drugs for Acute Treatment. Issue date: February 16, 2018. Get complete insights and analysis.

---

## Details

- Title: Migraine: Developing Drugs for Acute Treatment
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-02-16
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2014-D-1540">FDA-2014-D-1540</a>

## Related Documents

- [Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/allergic-rhinitis-developing-drug-products-for-treatment-guidance-for-industry/dcca7128-d84a-436f-83a2-e705904c701f)
- [Hypertension: Developing Fixed-Dose Combination Drugs for Treatment](https://www.keypedia.com/guidances/guidance-document/hypertension-developing-fixed-dose-combination-drugs-for-treatment/1a5d992e-fb16-402a-8d7a-11d62e5e766f)
- [Nonallergic Rhinitis:  Developing Drug Products for Treatment](https://www.keypedia.com/guidances/guidance-document/nonallergic-rhinitis-developing-drug-products-for-treatment/5453a88f-6b6b-4771-8248-e324727993ad)